author-photo

Anne F. Schott

University of Michigan

115

Papers

7244

Citations

Citation Trend

Filter By

Papers (115) Sort By

JournalConferenceOthers

A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (14)
Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (35)
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-11-07: A randomized phase II trial of reparixin, a CXCR1 inhibitor, in combination with paclitaxel in the treatment of mTNBC

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Investigating potential disparities in clinical trial eligibility, offers and enrollment at an NCI-designated comprehensive cancer center.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Endocrine therapy discontinuation rates in older women with early stage breast cancer who are candidates for omission of radiation.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号